Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PMCBPharmaCyte Biotech, Inc.

Nasdaq · CIK 0001157075
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end0430
XBRL facts407

Identity from submissions API

NamePharmaCyte Biotech, Inc.
CIK0001157075
TickersPMCB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN621772151
LEI—
Fiscal year end0430
State of incorporationNV NV
Phone(917) 595.2850
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • NUVILEX, INC. (2009-03-26T00:00:00.000Z → 2015-01-09T00:00:00.000Z)
  • EFOODSAFETY COM INC (2001-08-20T00:00:00.000Z → 2009-03-17T00:00:00.000Z)
Business address
3960 HOWARD HUGHES PARKWAY
SUITE 500
LAS VEGAS
NV
89169
NV
Mailing address
3960 HOWARD HUGHES PARKWAY
SUITE 500
LAS VEGAS
NV
89169
NV

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

474 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K CURRENT REPORT 1.01,2.01,9.01 0001683168-26-008964 001-40699 261575876 34 266590 1 1
2026-11-13 8-K CURRENT REPORT 3.03,5.03,8.01,9.01 0001683168-26-008705 001-40699 261553036 34 219745 1 1
2026-10-16 8-K FORM 8-K 4.01,9.01 0001683168-26-007934 001-40699 261466808 34 201850 1 1
2026-09-14 10-Q FORM 10-Q FOR JUL 2026 0001683168-26-007106 001-40699 261377388 34 4902949 1 1
2026-07-29 10-K FORM 10-K FOR APRIL 2026 0001683168-26-005836 001-40699 261218675 34 9354245 1 1
2026-07-17 4/A xslF345X06/ownership.xml 0001683168-26-005622 5983
2026-07-17 4/A xslF345X06/ownership.xml 0001683168-26-005621 6021
2026-07-17 4/A xslF345X06/ownership.xml 0001683168-26-005620 6002
2026-07-17 4/A xslF345X06/ownership.xml 0001683168-26-005619 5982
2026-04-02 4 xslF345X06/ownership.xml 0001683168-26-002633 5757
2026-04-02 4 xslF345X06/ownership.xml 0001683168-26-002632 5755
2026-04-02 4 xslF345X06/ownership.xml 0001683168-26-002631 5777
2026-04-02 4 xslF345X06/ownership.xml 0001683168-26-002630 13114
2026-04-02 8-K FORM 8-K 5.02,5.07,9.01 0001683168-26-002613 001-40699 26833896 34 357203 1 1
2026-03-18 4 xslF345X06/ownership.xml 0001683168-26-001989 001-40492 26770174 34 3929
2026-03-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001683168-26-001988 9614
2026-03-17 10-Q FORM 10-Q FOR JAN 2026 0001683168-26-001917 001-40699 26761524 34 6763572 1 1
2026-03-09 ARS ANNUAL REPORT 0001683168-26-001600 001-40699 26733455 34 1679356
2026-03-09 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-26-001593 001-40699 26733095 34 2612308 1 1
2026-02-27 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-26-001363 001-40699 26701558 34 1237406 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-016526 005-91495 26634047 34 17916
2026-01-07 4 xslF345X05/ownership.xml 0001683168-26-000148 15701
2026-01-07 4 xslF345X05/ownership.xml 0001683168-26-000147 7747
2025-12-18 10-Q FORM 10-Q FOR OCT 2025 0001683168-25-009259 001-40699 251583859 34 6201878 1 1
2025-12-15 NT 10-Q EXTENSION 0001683168-25-009154 001-40699 251571472 34 20489
2025-12-12 4 xslF345X05/ownership.xml 0001683168-25-009116 8990
2025-12-12 4 xslF345X05/ownership.xml 0001683168-25-009115 8985
2025-12-12 4 xslF345X05/ownership.xml 0001683168-25-009114 7277
2025-12-12 4 xslF345X05/ownership.xml 0001683168-25-009113 16347
2025-12-12 4 xslF345X05/ownership.xml 0001683168-25-009112 9732
2025-12-05 8-K FORM 8-K 3.01 0001683168-25-008947 001-40699 251553682 34 194062 1 1
2025-11-18 4 xslF345X05/ownership.xml 0001683168-25-008517 001-36268 251495225 34 8811
2025-11-18 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001683168-25-008515 17666
2025-11-18 8-K/A 8-K/A 9.01 0001683168-25-008512 001-40699 251494609 34 2165640 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-107726 005-91495 251463736 34 18641
2025-10-31 8-K FORM 8-K 5.02,5.07,9.01 0001683168-25-007871 001-40699 251440527 34 350796 1 1
2025-10-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-25-007435 001-40699 251377561 34 1125390
2025-09-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003122 333-290311 251351959 33 1979
2025-09-24 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-25-007217 001-40699 251338858 34 312622
2025-09-24 CORRESP filename1.htm 0001683168-25-007214 8174
2025-09-23 UPLOAD filename1.pdf 0000000000-25-010346 333-290311 40354
2025-09-17 S-3 FORM S-3 0001683168-25-007041 333-290311 251318412 33 23452024 1 1
2025-09-15 10-Q FORM 10-Q FOR JUL 2025 0001683168-25-006991 001-40699 251314788 34 4570948 1 1
2025-09-05 8-K FORM 8-K 1.01,2.01,7.01,9.01 0001683168-25-006727 001-40699 251296792 34 1417858 1 1
2025-09-04 D xslFormDX01/primary_doc.xml 06b 0001683168-25-006676 021-556587 251291745 33 11310
2025-08-18 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001683168-25-006274 001-40699 251226436 34 1490366 1 1
2025-08-11 10-K FORM 10-K FOR APR 2025 0001683168-25-005821 001-40699 251199634 34 7885626 1 1
2025-07-29 NT 10-K EXTENSION 0001683168-25-005492 001-40699 251163125 34 22222
2025-04-24 8-K FORM 8-K 5.07 0001683168-25-002790 001-40699 25868299 34 207129 1 1
2025-03-17 10-Q FORM 10-Q FOR JAN 2025 0001683168-25-001669 001-40699 25745685 34 5304349 1 1
2025-03-10 ARS FORM ARS 0001683168-25-001469 001-40699 25724082 34 2675284
2025-03-10 DEFA14A FORM DEFA 14A 0001683168-25-001466 001-40699 25723959 34 487206
2025-03-10 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-25-001464 001-40699 25723924 34 915402
2025-02-26 8-K FORM 8-K 4.01,9.01 0001683168-25-001236 001-40699 25668896 34 207048 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-006360 005-91495 25619030 34 12044
2025-01-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-003823 005-91495 25532920 34 15903
2024-12-13 10-Q FORM 10-Q FOR OCTOBER 2024 0001683168-24-008709 001-40699 241548260 34 4973697 1 1
2024-12-04 S-8 REGISTRATION STATEMENT 0001683168-24-008523 333-283613 241527152 33 101921
2024-11-13 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-24-097260 005-91495 241452119 34 72096
2024-09-17 10-Q FORM 10-Q FOR JULY 2024 0001683168-24-006441 001-40699 241302325 34 4931872 1 1
2024-09-17 NT 10-Q EXTENSION 0001683168-24-006432 001-40699 241302109 34 21112
2024-08-13 10-K FORM 10-K FOR APRIL 2024 0001683168-24-005575 001-40699 241202313 34 7318247 1 1
2024-07-29 NT 10-K FORM 12B-25 0001683168-24-005109 001-40699 241152298 34 20061
2024-07-17 4 xslF345X05/ownership.xml 0001683168-24-004918 5751
2024-07-17 4 xslF345X05/ownership.xml 0001683168-24-004917 5748
2024-07-17 4 xslF345X05/ownership.xml 0001683168-24-004916 5735
2024-07-17 4 xslF345X05/ownership.xml 0001683168-24-004915 5748
2024-05-30 3 xslF345X02/ownership.xml 0001683168-24-003882 001-36268 241005154 34 7008
2024-05-30 SC 13D SCHEDULE 13D 0001683168-24-003883 52660
2024-05-23 8-K FORM 8-K 1.01,2.01,8.01,9.01 0001683168-24-003796 001-40699 24978988 34 1686639 1 1
2024-05-01 8-K FORM 8-K 5.07 0001683168-24-002881 001-40699 24902910 34 206615 1 1
2024-03-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-24-001762 001-40699 24790611 34 1703032
2024-03-27 ARS ANNUAL REPORT 0001683168-24-001761 001-40699 24790563 34 2360444
2024-03-18 10-Q FORM 10-Q FOR JAN 2024 0001683168-24-001525 001-40699 24758921 34 5738839 1 1
2024-02-14 SC 13G formsc13g.htm 0001493152-24-006568 005-91495 24636978 34 191112
2024-02-06 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-24-010294 005-91495 24598534 34 73266
2023-12-15 10-Q FORM 10-Q FOR OCTOBER 2023 0001683168-23-008889 001-40699 231491462 34 5019680 1 1
2023-11-28 3 xslF345X02/ownership.xml 0001683168-23-008503 001-40492 231447395 34 6519
2023-11-24 8-K FORM 8-K 5.02 0001683168-23-008446 001-40699 231436704 34 197545 1 1
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008434 5313
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008433 5318
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008432 5450
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008431 5510
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008430 5336
2023-11-22 4 xslF345X05/ownership.xml 0001683168-23-008429 5350
2023-11-22 SC 13D FORM SC-13D 0001683168-23-008419 60343
2023-11-16 8-K CURRENT REPORT 1.01,8.01,9.01 0001683168-23-008204 001-40699 231412219 34 1568027 1 1
2023-11-09 8-K CURRENT REPORT 4.01 0001683168-23-007830 001-40699 231393886 34 199573 1 1
2023-09-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-29 16:01:00 9999999995-23-002857 333-272569 231297469 33 1921
2023-09-27 CORRESP filename1.htm 0001683168-23-006761 7680
2023-09-21 S-3/A S-3/A 0001683168-23-006602 333-272569 231269699 33 430302 1 1
2023-09-18 10-Q FORM 10-Q 0001683168-23-006505 001-40699 231260037 34 4574134 1 1
2023-09-15 NT 10-Q FORM 12B-25 0001683168-23-006491 001-40699 231259335 34 20903
2023-09-12 S-3/A AMENDMENT 2 0001683168-23-006374 333-272569 231248918 33 469462 1 1
2023-09-07 8-K FORM 8-K 5.03,5.07,9.01 0001683168-23-006331 001-40699 231242279 34 636056 1 1
2023-08-04 CORRESP filename1.htm 0001683168-23-005301 21252
2023-08-04 S-3/A AMENDMENT NO. 1 0001683168-23-005299 333-272569 231144584 33 269993
2023-08-04 8-K FORM 8-K 4.01,9.01 0001683168-23-005293 001-40699 231143913 34 210653 1 1
2023-07-31 10-K ANNUAL REPORT 0001683168-23-005175 001-40699 231128450 34 6366407 1 1
2023-07-31 DEF 14A DEFINITIVE PROXY 0001683168-23-005167 001-40699 231127922 34 423488
2023-07-19 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-23-004986 001-40699 231095913 34 151510
2023-07-19 8-K CURRENT REPORT 5.03,8.01,9.01 0001683168-23-004985 001-40699 231095306 34 212156 1 1
2023-06-26 UPLOAD filename1.pdf 0000000000-23-006796 47969
2023-06-16 SC 13D/A sc13da507004013_06162023.htm 0000921895-23-001535 005-91495 231022342 34 177598
2023-06-15 SC TO-I/A SC TO-I/A 0001683168-23-004178 005-91495 231017291 34 43746
2023-06-09 S-3 REGISTRATION STATEMENT 0001683168-23-004053 333-272569 231006073 33 230489
2023-06-05 DEF 14A DEF 14A 0001683168-23-003905 001-40699 23992463 34 1104339
2023-06-05 CORRESP filename1.htm 0001683168-23-003902 27228
2023-05-30 CORRESP filename1.htm 0001683168-23-003744 10366
2023-05-25 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-23-003706 001-40699 23961973 34 129052
2023-05-19 SC 13G formsc13g.htm 0001493152-23-018409 005-91495 23941546 34 175937
2023-05-19 UPLOAD filename1.pdf 0000000000-23-005380 44445
2023-05-12 SC 13D/A AMENDMENT NO. 4 TO THE SCHEDULE 13D 0000921895-23-001173 005-91495 23916139 34 205907
2023-05-11 SC TO-I SCHEDULE TO-I 0001683168-23-003170 005-91495 23909023 34 788781
2023-05-11 8-K FORM 8-K 1.01,3.02,5.03,5.07,8.01,9.01 0001683168-23-003169 001-40699 23909007 34 1978289 1 1
2023-03-16 10-Q FORM 10-Q 0001683168-23-001559 001-40699 23739437 34 5598887 1 1
2023-02-14 SC 13G/A e618259_sc13ga-pharmacyte.htm 0001193805-23-000217 005-91495 23630166 34 73709
2023-02-08 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-23-009110 005-91495 23596931 34 66385
2023-02-02 8-K FORM 8-K 8.01,9.01 0001683168-23-000500 001-40699 23578977 34 223681 1 1
2023-01-10 SC 13G/A SABBY 13GA PMCB 1.10.23 0001535610-23-000018 005-91495 23520265 34 13354
2022-12-30 3 xslF345X02/ownership.xml 0001683168-22-008708 16182
2022-12-30 4 xslF345X03/ownership.xml 0001683168-22-008707 5689
2022-12-30 4 xslF345X03/ownership.xml 0001683168-22-008706 5729
2022-12-30 8-K FORM 8-K 5.07 0001683168-22-008705 001-40699 221502021 34 221763 1 1
2022-12-14 10-Q FORM 10-Q 0001683168-22-008428 001-40699 221462966 34 4971263 1 1
2022-11-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-22-008032 001-40699 221417978 34 1077832
2022-11-18 8-K FORM 8-K 5.02,5.03,9.01 0001683168-22-007894 001-40699 221401891 34 216095 1 1
2022-11-16 3 xslF345X02/ownership.xml 0001683168-22-007819 16003
2022-11-15 PRE 14A SCHEDULE 14A 0001683168-22-007786 001-40699 221391740 34 571879
2022-11-07 8-K FORM 8-K 5.02 0001683168-22-007359 001-40699 221366273 34 198910 1 1
2022-10-20 SC 13G e621790_sc13g-pharmacyte.htm 0001193805-22-001435 005-91495 221320323 34 70888
2022-10-14 8-K FORM 8-K 5.02,5.08,8.01,9.01 0001683168-22-006911 001-40699 221311497 34 243254 1 1
2022-10-07 8-K FORM 8-K 5.02,7.01,9.01 0001683168-22-006803 001-40699 221301261 34 333289 1 1
2022-09-14 10-Q FORM 10-Q 0001683168-22-006394 001-40699 221243354 34 4643289 1 1
2022-08-24 3 xslF345X02/ownership.xml 0001683168-22-006030 3824
2022-08-23 3 xslF345X02/ownership.xml 0001683168-22-006029 3742
2022-08-23 3 xslF345X02/ownership.xml 0001683168-22-006028 9365
2022-08-23 3 xslF345X02/ownership.xml 0001683168-22-006023 3875
2022-08-23 3 xslF345X02/ownership.xml 0001683168-22-006007 4880
2022-08-16 8-K CURRENT REPORT 1.01,5.02,7.01,9.01 0001683168-22-005782 001-40699 221167943 34 187534
2022-08-16 DEFA14A CURRENT REPORT 0001683168-22-005783 001-40699 221167931 34 187185
2022-08-15 SC 13D/A AMENDMENT NO. 3 TO THE SCHEDULE 13D 0000921895-22-002477 005-91495 221167025 34 492387
2022-07-28 10-K FORM 10-K 0001683168-22-005189 001-40699 221116417 34 9206147 1 1
2022-07-28 8-K FORM 8-K 8.01,9.01 0001683168-22-005186 001-40699 221116233 34 60249
2022-07-28 DEFA14A FORM 8-K 0001683168-22-005187 001-40699 221116220 34 60139
2022-07-28 DFAN14A dfan14a07004013_07282022.htm 0000921895-22-002292 001-40699 221115377 34 25604
2022-07-26 PREC14A prec14a07004013_07262022.htm 0000921895-22-002285 001-40699 221107893 34 370893
2022-07-21 8-K CURRENT REPORT 8.01,9.01 0001683168-22-005063 001-40699 221096855 34 40925
2022-07-21 DEFA14A CURRENT REPORT 0001683168-22-005064 001-40699 221096842 34 40815
2022-07-19 8-K CURRENT REPORT 8.01,9.01 0001683168-22-005036 001-40699 221092247 34 40526
2022-07-19 DEFA14A CURRENT REPORT 0001683168-22-005037 001-40699 221092206 34 40416
2022-07-11 DFAN14A dfan14a11375004_07112022.htm 0000921895-22-002215 001-40699 221077728 34 408116
2022-07-11 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-22-002213 005-91495 221077550 34 466322
2022-07-11 8-K FORM 8-K 2.02,8.01,9.01 0001683168-22-004874 001-40699 221077169 34 46589
2022-07-11 DEFA14A FORM 8-K 0001683168-22-004875 001-40699 221077146 34 46414
2022-07-05 DFAN14A dfan14a11375004_07052022.htm 0000921895-22-002140 001-40699 221064498 34 27812
2022-06-23 DFAN14A dfan14a11375004_06232022.htm 0000921895-22-002078 001-40699 221035633 34 512280
2022-06-23 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-22-002076 005-91495 221035319 34 443777
2022-06-15 8-K CURRENT REPORT 8.01,9.01 0001683168-22-004361 001-40699 221016687 34 50251
2022-06-15 DEFA14A CURRENT REPORT 0001683168-22-004362 001-40699 221016685 34 50141
2022-06-07 8-K FORM 8-K 5.08,8.01 0001683168-22-004190 001-40699 22999725 34 199952 1 1
2022-04-13 8-K FORM 8-K 5.02,8.01 0001683168-22-002580 001-40699 22823662 34 199206 1 1
2022-04-11 3 xslF345X02/ownership.xml 0001683168-22-002485 4075
2022-04-05 8-K CURRENT REPORT 5.02,7.01,9.01 0001683168-22-002335 001-40699 22805094 34 232141 1 1
2022-03-15 10-Q FORM 10-Q 0001683168-22-001694 001-40699 22742247 34 5057647 1 1
2022-03-09 8-K FORM 8-K 7.01,9.01 0001683168-22-001550 001-40699 22726411 34 5498964 1 1
2022-03-01 8-K FORM 8-K 3.01 0001683168-22-001345 001-40699 22693290 34 196656 1 1
2022-02-17 8-K FORM 8-K 3.01 0001683168-22-001119 001-40699 22649330 34 195853 1 1
2022-02-11 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-006702 005-91495 22616772 34 67171
2022-01-04 SC 13G/A SABBY 13G-A PMCB 1.04.22 0001535610-22-000026 005-91495 22504524 34 13521
2021-12-14 10-Q FORM 10-Q 0001683168-21-006337 001-40699 211491925 34 4911384 1 1
2021-11-22 424B3 FORM 423B2 0001683168-21-005868 333-260849 211430022 33 385614
2021-11-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-11-17 17:30:00 9999999995-21-004386 333-260849 211422482 33 1921
2021-11-15 CORRESP filename1.htm 0001683168-21-005710 6365
2021-11-15 UPLOAD filename1.pdf 0000000000-21-013789 40431
2021-11-08 S-3 FORM S-3 0001683168-21-005280 333-260849 211385909 33 549307
2021-11-04 SC 13D c102497_sc13d.htm 0000930413-21-001835 005-91495 211378042 34 294807
2021-09-14 10-Q FORM 10-Q FOR JULY 31, 2021 0001683168-21-004264 001-40699 211251258 34 4392337 1 1
2021-09-10 8-K FORM 8-K 7.01,9.01 0001683168-21-004199 001-40699 211245461 34 4400008 1 1
2021-09-03 3 xslF345X02/ownership.xml 0001683168-21-004118 9683
2021-09-01 D xslFormDX01/primary_doc.xml 06b 0001683168-21-004022 021-411887 211228236 33 12152
2021-08-31 3 xslF345X02/ownership.xml 0001683168-21-004020 9806
2021-08-31 3 xslF345X02/ownership.xml 0001683168-21-004019 9465
2021-08-31 3 xslF345X02/ownership.xml 0001683168-21-004018 9730
2021-08-30 SC 13G SABBY 13G PMCB 8.30.21 0001535610-21-000094 005-91495 211221131 34 13517
2021-08-30 SC 13G SCHEDULE 13G 0001213900-21-045460 005-91495 211220826 34 107993
2021-08-23 424B5 PROSPECTUS SUPPLEMENT 0001683168-21-003828 333-255044 211195288 33 748585
2021-08-23 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001683168-21-003829 001-40699 211195287 34 705698
2021-08-20 3 xslF345X02/ownership.xml 0001683168-21-003827 10638
2021-08-20 3 xslF345X02/ownership.xml 0001683168-21-003826 8483
2021-08-20 3 xslF345X02/ownership.xml 0001683168-21-003825 11541
2021-08-19 S-3MEF FORM S-3 MEF 0001683168-21-003773 333-258921 211188368 33 101354
2021-08-12 8-K FORM 8-K 1.01,7.01,9.01 0001683168-21-003431 001-40699 211165398 34 759095
2021-08-10 CERT 8A CERT 0001354457-21-000914 001-40699 211158536 34 644921
2021-08-10 10-K FORM 10-K 0001683168-21-003377 001-40699 211158302 34 4895507 1
2021-08-10 424B5 PROSPECTUS SUPPLEMENT 0001683168-21-003375 333-255044 211158289 33 795035
2021-08-02 8-K CURRENT REPORT 8.01 0001683168-21-003222 001-40699 211136935 34 21209
2021-08-02 424B5 PROSPECTUS SUPPLEMENT 0001683168-21-003220 333-255044 211136918 33 795897
2021-08-02 8-A12B REGISTRATION OF CERTAIN CLASSES OF SECURITIES 0001683168-21-003192 001-40699 211134040 34 22514
2021-07-29 NT 10-K NOTICE OF LATE FILING 0001683168-21-003162 333-68008 211127865 34 18482
2021-07-13 8-K FORM 8-K 8.01,9.01 0001683168-21-002921 333-68008 211086443 34 213532
2021-07-06 8-K FORM 8-K 5.07,8.01,9.01 0001683168-21-002825 333-68008 211072225 34 1733029
2021-06-22 8-K FORM 8-K 8.01,9.01 0001683168-21-002661 333-68008 211032758 34 26974
2021-06-15 8-K CURRENT REPORT 8.01,9.01 0001683168-21-002553 333-68008 211016457 34 41185
2021-06-04 8-K FORM 8-K 8.01,9.01 0001683168-21-002359 333-68008 21994657 34 33018
2021-05-06 8-K FORM 8-K 8.01,9.01 0001683168-21-001793 333-68008 21895469 34 699486
2021-04-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-14 17:00:00 9999999995-21-001434 333-255044 21827161 33 1920
2021-04-12 CORRESP filename1.htm 0001683168-21-001331 7813
2021-04-09 UPLOAD filename1.pdf 0000000000-21-004343 40422
2021-04-05 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-21-001234 333-255044 21806454 33 845389
2021-03-12 10-Q FORM 10-Q 0001683168-21-000925 333-68008 21738441 34 3576098 1
2020-12-11 10-Q QUARTERLY REPORT 0001683168-20-004267 333-68008 201383997 34 3341971 1
2020-10-16 8-K FORM 8-K 5.02,9.01 0001683168-20-003473 333-68008 201244508 34 33508
2020-09-11 10-Q QUARTERLY REPORT 0001683168-20-003111 333-68008 201171273 34 3150124 1
2020-08-13 10-K FORM 10-K 0001683168-20-002680 333-68008 201100150 34 4477100 1
2020-07-29 SC 13D/A SC 13D/A 0001753926-20-000215 005-91495 201057592 34 65586
2020-07-29 NT 10-K EXTENSION 0001683168-20-002412 333-68008 201057475 34 18449
2020-05-06 SC 13D SC 13D 0001753926-20-000100 005-91495 20852177 34 83858
2020-04-08 8-K FORM 8-K 7.01,8.01,9.01 0001683168-20-001127 333-68008 20781117 34 228328
2020-03-13 10-Q FORM 10-Q 0001683168-20-000802 333-68008 20713458 34 6301563 1
2020-01-21 8-K FORM 8-K 1.01,3.02,9.01 0001683168-20-000204 333-68008 20537002 34 68211
2019-12-23 10-Q FORM 10-Q 0001683168-19-004051 333-68008 191306576 34 3292172 1
2019-12-16 NT 10-Q EXTENSION 0001683168-19-003968 333-68008 191285424 34 18351
2019-11-08 8-K FORM 8-K 5.03,9.01 0001683168-19-003515 333-68008 191205137 34 897063
2019-10-03 8-K FORM 8-K 5.03,9.01 0001683168-19-003157 333-68008 191135545 34 65159
2019-09-13 10-Q FORM 10-Q 0001683168-19-002926 333-68008 191093221 34 2786535 1
2019-08-26 8-K FORM 8-K 8.01,9.01 0001683168-19-002754 333-68008 191050514 34 344216
2019-08-13 10-K FORM 10-K 0001683168-19-002559 333-68008 191018104 34 4323923 1
2019-07-29 NT 10-K NOTICE OF LATE FILING 0001683168-19-002373 333-68008 19981943 34 18332
2019-03-14 10-Q FORM 10-Q 0001683168-19-000666 333-68008 19681964 34 2836461 1
2018-12-14 10-Q FORM 10-Q 0001683168-18-003717 333-68008 181236446 34 2978895 1
2018-09-12 10-Q FORM 10-Q 0001683168-18-002721 333-68008 181067443 34 2584369 1
2018-07-20 10-K FORM 10-K 0001683168-18-001994 333-68008 18963034 34 4944027 1
2018-05-15 8-K FORM 8-K 1.01,9.01 0001683168-18-001309 333-68008 18832498 34 97315
2018-03-19 10-Q FORM 10-Q 0001683168-18-000720 333-68008 18699238 34 3006150 1
2018-02-22 424B5 FORM 424(B)(5) 0001683168-18-000495 333-220441 18632823 33 372621
2018-02-22 8-K FORM 8-K 1.01,1.02,9.01 0001683168-18-000494 333-68008 18632773 34 176112
2017-12-14 10-Q FORM 10-Q 0001683168-17-003310 333-68008 171256665 34 2901440 1
2017-11-06 UPLOAD filename1.pdf 0000000000-17-039129 136952
2017-10-10 8-K FORM 8-K 5.02,7.01,9.01 0001683168-17-002610 333-68008 171128749 34 85210
2017-09-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-09-28 09:00:00 9999999995-17-002498 333-220441 171108869 33 1915
2017-09-28 424B3 PROSPECTUS SUPPLEMENT 0001683168-17-002504 333-220441 171107636 33 237373
2017-09-26 CORRESP filename1.htm 0001683168-17-002478 7653
2017-09-13 S-3 FORM S-3 0001683168-17-002356 333-220441 171082340 33 1072619
2017-09-13 10-Q FORM 10-Q 0001683168-17-002358 333-68008 171082086 34 2871300 1
2017-09-06 8-K FORM 8-K 1.01,7.01,9.01 0001683168-17-002311 333-68008 171070220 34 69329
2017-07-27 10-K FORM 10-K 0001683168-17-001881 333-68008 17987124 34 4476150 1
2017-07-10 8-K FORM 8-K 5.02,7.01,9.01 0001683168-17-001742 333-68008 17956268 34 76201
2017-05-02 8-K CURRENT REPORT 5.02,7.01,9.01 0001683168-17-001069 333-68008 17802968 34 76522
2017-03-13 10-Q/A AMENDMENT FOR XBRL 0001683168-17-000544 333-68008 17684079 34 2261567 1
2017-03-13 10-Q FORM 10-Q 0001683168-17-000541 333-68008 17683975 34 691269
2016-12-21 8-K FORM 8-K 1.01,9.01 0001683168-16-001004 333-68008 162062726 34 45492
2016-12-02 10-Q 10-Q 0001683168-16-000848 333-68008 162032093 34 2612432 1
2016-09-06 10-Q QUARTERLY REPORT 0001683168-16-000026 333-68008 161871519 34 2362015 1
2016-07-29 10-K FORM 10-K 0001019687-16-007057 333-68008 161795079 34 4886039 1
2016-07-14 NT 10-K FORM 12B-25 (NT 10-K) 0001019687-16-006933 333-68008 161767502 34 22494
2016-03-08 10-Q FORM 10-Q 0001019687-16-005399 333-68008 161492600 34 2194461 1
2016-03-03 UPLOAD filename1.pdf 0000000000-16-067075 38914
2016-03-02 10-K/A FORM 10-K - AMENDMENT 3 0001019687-16-005316 333-68008 161477905 34 515760
2016-02-02 CORRESP filename1.htm 0001019687-16-004993 38606
2016-01-28 UPLOAD filename1.pdf 0000000000-16-062868 161899
2016-01-19 10-K/A AMENDMENT NO. 2 0001019687-16-004873 333-68008 161349189 34 5129777 1
2016-01-19 10-Q/A AMENDMENT NO. 2 0001019687-16-004872 333-68008 161349178 34 2747659 1
2016-01-19 D xslFormDX01/primary_doc.xml 06b 0001019687-16-004862 021-255391 161346887 33 9229
2016-01-19 10-Q/A AMENDMENT NO. 1 0001019687-16-004860 333-68008 161346883 34 2745378 1
2016-01-19 10-Q/A AMENDMENT NO. 1 0001019687-16-004858 333-68008 161346874 34 2585994 1
2016-01-19 10-K/A AMENDMENT NO. 1 0001019687-16-004856 333-68008 161346863 34 5128596 1
2016-01-12 8-K FORM 8-K 1.01,3.02,9.01 0001019687-16-004784 333-68008 161339426 34 400733
2015-12-31 8-K CURRENT REPORT 4.02,5.02 0001019687-15-004674 333-68008 151315101 34 31497
2015-12-10 10-Q FORM 10-Q 0001019687-15-004472 333-68008 151281330 34 2175269 1
2015-11-02 8-K CURRENT REPORT 4.01,9.01 0001019687-15-003870 333-68008 151190774 34 19756
2015-10-02 8-K FORM 8-K 5.02 0001019687-15-003617 333-68008 151141153 34 12938
2015-08-25 10-Q QUARTERLY REPORT 0001019687-15-003255 333-68008 151071749 34 2129024 1
2015-07-29 10-K ANNUAL REPORT 0001019687-15-002894 333-68008 151012739 34 4309034 1
2015-07-14 NT 10-K NOTICE OF LATE FILING 0001019687-15-002727 333-68008 15987542 34 25716
2015-05-28 8-K PHARMACYTE BIOTECH, INC. 4.01,9.01 0001019687-15-002167 333-68008 15893297 34 27463
2015-04-29 8-K FORM 8-K 5.02,9.01 0001019687-15-001655 333-68008 15810267 34 56452
2015-03-13 10-Q FORM 10-Q 0001019687-15-000953 333-68008 15700331 34 2780141 1
2015-01-20 CT ORDER filename1.pdf 20150120,20150120 9999999997-15-000227 333-68008 15536505 34 11399
2015-01-09 8-K PHARMACYTE BIOTECH, INC. 5.03,7.01,9.01 0001019687-15-000112 333-68008 15518153 34 128916
2014-12-15 10-Q FORM 10-Q 0001019687-14-004716 333-68008 141287027 34 2616356 1
2014-12-02 424B5 PROSPECTUS SUPPLEMENT 0001019687-14-004555 333-199440 141261525 33 257580
2014-12-01 8-K FORM 8-K 1.01,9.01 0001019687-14-004534 333-68008 141256506 34 34948
2014-11-12 424B5 PROSPECTUS SUPPLEMENT 0001019687-14-004189 333-199440 141212681 33 257096
2014-10-29 424B2 PROSPECTUS 0001019687-14-003986 333-199440 141178614 33 177203
2014-10-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2014-10-28 17:30:00 9999999995-14-003164 333-199440 141178477 33 1805
2014-10-24 S-3/A AMENDMENT NO. 1 0001019687-14-003954 333-199440 141172955 33 108418
2014-10-17 S-3 FORM S-3 REGISTRATION STATEMENT 0001019687-14-003904 333-199440 141161938 33 999970
2014-10-17 10-K/A FORM 10-K AMENDMENT 0001019687-14-003893 333-68008 141160431 34 987571
2014-10-17 10-K/A FORM 10-K AMENDMENT 0001019687-14-003892 333-68008 141160430 34 287235
2014-10-15 CT ORDER filename1.pdf 20141014,20141015 9999999997-14-014350 333-68008 141156022 34 14601
2014-10-14 UPLOAD filename1.pdf 0000000000-14-051187 36649
2014-10-06 CORRESP filename1.htm 0001019687-14-003803 40837
2014-10-03 8-K CURRENT REPORT ON FORM 8-K 1.01,5.02,5.03,9.01 0001019687-14-003787 333-68008 141140939 34 249545
2014-10-01 UPLOAD filename1.pdf 0000000000-14-049280 166799
2014-09-25 8-K FORM 8-K 1.01,5.02,5.03,5.05,8.01,9.01 0001019687-14-003701 333-68008 141119536 34 591773
2014-09-15 10-Q QUARTERLY REPORT 0001019687-14-003582 333-68008 141102181 34 1954850 1
2014-09-12 CORRESP filename1.htm 0001019687-14-003570 22392
2014-09-12 UPLOAD filename1.pdf 0000000000-14-045813 159435
2014-08-15 CORRESP filename1.htm 0001019687-14-003235 47148
2014-08-05 UPLOAD filename1.pdf 0000000000-14-039461 166589
2014-08-04 10-K FORM 10-K 0001019687-14-002942 333-68008 141011537 34 3990293 1
2014-07-30 NT 10-K NOTICE OF LATE FILING 0001019687-14-002869 333-68008 141002588 34 24170
2014-07-11 CORRESP filename1.htm 0001019687-14-002710 118478
2014-06-30 UPLOAD filename1.pdf 0000000000-14-032922 218611
2014-05-29 8-K CURRENT REPORT ON FORM 8-K 1.01,1.02,9.01 0001019687-14-002185 333-68008 14873842 34 247609
2014-05-27 CORRESP filename1.htm 0001019687-14-002153 167658
2014-05-05 CORRESP filename1.htm 0001019687-14-001641 4802
2014-05-02 CORRESP filename1.htm 0001019687-14-001639 4578
2014-04-24 UPLOAD filename1.pdf 0000000000-14-020830 210059
2014-03-25 8-K FORM 8-K 1.01,9.01 0001019687-14-000974 333-68008 14714252 34 26341
2014-03-20 8-K FORM 8-K 8.01,9.01 0001019687-14-000911 333-68008 14705572 34 29843
2014-03-17 10-Q QUARTERLY REPORT 0001019687-14-000850 333-68008 14696031 34 2185888 1
2014-03-06 8-K CURRENT REPORT ON FORM 8-K 1.01 0001019687-14-000740 333-68008 14674207 34 13098
2014-02-19 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001019687-14-000585 333-68008 14626729 34 395022
2013-12-27 D xslFormDX01/primary_doc.xml 06b 0001019687-13-005003 021-208868 131301215 33 10765
2013-12-16 10-Q QUARTERLY REPORT 0001019687-13-004824 333-68008 131277604 34 2283072 1
2013-12-02 8-K FORM 8-K 1.01,8.01,9.01 0001019687-13-004678 333-68008 131252010 34 25533
2013-11-25 8-K FORM 8-K 5.02,8.01,9.01 0001019687-13-004633 333-68008 131241514 34 27061
2013-09-16 10-Q 10-Q 0001157075-13-000015 333-68008 131097308 34 4452748 1
2013-07-30 10-K/A 10-K/A 0001157075-13-000012 333-68008 13995982 34 25639
2013-07-29 10-K 10-K 0001157075-13-000010 333-68008 13992717 34 5943882 1
2013-07-18 8-K 8-K 1.01,2.01,5.02,9.01 0001157075-13-000007 333-68008 13973690 34 975601
2013-04-25 10-Q/A FORM 10-Q/A2, QUARTER ENDED JULY 31, 2011 0001157075-13-000005 333-68008 13783133 34 17238
2013-03-26 10-Q 10-Q 0001445305-13-000706 333-68008 13715050 34 3319828 1
2013-03-18 NT 10-Q NT 10-Q 0001157075-13-000002 333-68008 13698216 34 23103
2013-02-15 8-K 8-K 2.01 0001445305-13-000233 333-68008 13619590 34 730739
2013-02-15 425 8-K 0001445305-13-000234 333-68008 13619581 34 731334
2012-12-26 10-Q 10-Q 0001445305-12-003886 333-68008 121285717 34 3292200 1
2012-12-17 NT 10-Q NT 10-Q 0001445305-12-003841 333-68008 121268829 34 23695
2012-09-19 10-Q FORM 10-Q 0001262463-12-000355 333-68008 121100087 34 2160836 1
2012-09-14 NT 10-Q NT 10-Q 0001262463-12-000352 333-68008 121093419 34 13517
2012-08-14 10-K FORM 10-K 0001262463-12-000335 333-68008 121032569 34 1991571 1
2012-07-30 NT 10-K FORM NT-10K 0001262463-12-000276 333-68008 12994102 34 12940
2012-06-28 8-K FORM 8-K 2.01,2.03,3.02,9.01 0001262463-12-000242 333-68008 12931005 34 162806
2012-03-26 10-Q/A FORM 10-Q/A 0001262463-12-000085 333-68008 12713553 34 49696
2012-03-21 10-Q FORM 10-Q 0001262463-12-000081 333-68008 12705895 34 1544640 1
2012-03-19 NT 10-Q NT-10Q 0001262463-12-000064 333-68008 12699643 34 12193
2012-03-01 UPLOAD filename1.pdf 0000000000-12-010929 48071
2012-02-29 8-K/A FORM 8-K/A 4.01,9.01 0001262463-12-000044 333-68008 12649273 34 16235
2012-02-28 CORRESP filename1.htm 0001262463-12-000045 8870
2012-02-21 UPLOAD filename1.pdf 0000000000-12-009088 59351
2012-02-15 8-K FORM 8-K 4.01,9.01 0001262463-12-000033 333-68008 12615575 34 15463
2012-01-24 8-K ITEM 5.02 5.02 0001262463-12-000015 333-68008 12542639 34 11160
2011-12-15 10-Q FORM 10-Q 0001262463-11-000325 333-68008 111263250 34 1462474 1
2011-09-20 10-Q/A FORM 10-Q/A 0001262463-11-000192 333-68008 111099748 34 1188095 1
2011-09-19 10-Q FORM 10-Q 0001262463-11-000184 333-68008 111097232 34 370847
2011-09-14 NT 10-Q NT-10Q 0001262463-11-000164 333-68008 111090622 34 11741
2011-08-15 10-K FORM 10-K 0001262463-11-000129 333-68008 111035711 34 1527467
2011-08-01 NT 10-K NT-10K 0001262463-11-000106 333-68008 111000524 34 11786
2011-07-25 8-K FORM 8-K 3.01,9.01 0001262463-11-000098 333-68008 11983900 34 750487
2011-06-20 UPLOAD filename1.pdf 0000000000-11-037604 45549
2011-06-08 CORRESP filename1.htm 0001262463-11-000072 5479
2011-06-08 10-Q/A FORM 10-Q/A 0001262463-11-000071 333-68008 11901309 34 382982
2011-06-08 10-Q/A FORM 10-Q/A 0001262463-11-000070 333-68008 11901280 34 331702
2011-06-06 UPLOAD filename1.pdf 0000000000-11-034585 48211
2011-04-28 UPLOAD filename1.pdf 0000000000-11-026681 47041
2011-04-28 UPLOAD filename1.pdf 0000000000-11-026677 47049
2011-04-27 CORRESP filename1.htm 0001262463-11-000049 6282
2011-04-27 CORRESP filename1.htm 0001262463-11-000048 6257
2011-04-26 10-Q/A FORM 10-Q/A 0001262463-11-000047 333-68008 11780619 34 382240
2011-04-26 10-Q/A FORM 10-Q/A 0001262463-11-000046 333-68008 11780561 34 330972
2011-04-26 10-K/A FORM 10-KA 0001262463-11-000045 333-68008 11780544 34 658264
2011-04-26 8-K/A FORM 8-K/A 4.02 0001262463-11-000044 333-68008 11780515 34 145075
2011-03-08 10-Q FORM 10-Q 0001262463-11-000031 333-68008 11670037 34 402879
2011-03-07 UPLOAD filename1.pdf 0000000000-11-014158 59623
2011-03-02 8-K FORM 8-K ITEM 5.02 5.02 0001262463-11-000029 333-68008 11656363 34 12499
2011-03-02 CORRESP filename1.htm 0001262463-11-000028 7344
2011-03-02 8-K/A FORM 8-K 4.02 0001262463-11-000027 333-68008 11656050 34 154921
2011-02-15 UPLOAD filename1.pdf 0000000000-11-009946 57495
2011-02-03 8-K ITEM 5.02 5.02 0001262463-11-000018 333-68008 11569828 34 11785
2011-02-02 UPLOAD filename1.pdf 0000000000-11-006824 60705
2011-01-31 CORRESP filename1.htm 0001262463-11-000016 5626
2011-01-31 8-K FORM 8-K 4.02 0001262463-11-000015 333-68008 11558331 34 140211
2011-01-28 10-Q FORM 10-Q 0001262463-11-000012 333-68008 11553282 34 378558
2011-01-20 UPLOAD filename1.pdf 0000000000-11-004090 60015
2011-01-14 10-Q nuvilex10q7312010.htm 0001262463-11-000007 333-68008 11530554 34 267417
2011-01-14 8-K/A ITEM 3.01 AND 4.02 3.01,4.02 0001262463-11-000006 333-68008 11530528 34 15993
2010-12-29 10-K FORM 10-K 0001262463-10-000148 333-68008 101278384 34 542312
2010-12-16 NT 10-Q nvlx12b2510312010.htm 0001262463-10-000141 333-68008 101255301 34 11160
2010-11-12 NTN 10Q nvlx12b257312010.htm 0001262463-10-000130 333-68008 101186989 34 11557
2010-09-28 CORRESP filename1.htm 0001262463-10-000110 5228
2010-09-22 8-K ITEM 5.02 5.02 0001262463-10-000104 333-68008 101083608 34 12451
2010-09-20 UPLOAD filename1.pdf 0000000000-10-054844 59821
2010-09-15 8-K CURRENT REPORT 3.01,4.02,9.01 0001099910-10-000137 333-68008 101073701 34 38367
2010-07-30 NT 10-K QUARTERLY REPORT 0001099910-10-000082 333-68008 10978995 34 56248
2010-03-30 UPLOAD filename1.pdf 0000000000-10-017416 20397
2010-03-29 8-K/A AMENDMENT NO. 1 TO 8K 4.01,9.01 0001099910-10-000012 333-68008 10708854 34 41936
2010-03-26 CORRESP filename1.htm 0001099910-10-000011 20647
2010-03-22 10-Q QUARTERLY REPORT 0001099910-10-000008 333-68008 10696898 34 500004
2010-03-18 CORRESP filename1.htm 0001099910-10-000006 8920
2010-03-18 NT 10-Q NOTIFICATION OF LATE FILING 0001099910-10-000004 333-68008 10689973 34 32169
2010-03-11 UPLOAD filename1.pdf 0000000000-10-013583 24501
2010-03-09 8-K nvlx8kchangeinauditor.htm 4.01 0001262463-10-000019 333-68008 10665971 34 12802
2009-12-21 10-Q nuvilexform10q20091031.htm 0001262463-09-000104 333-68008 091252326 34 373100
2009-12-14 NT 10-Q nuvilexform12b25form10q.htm 0001262463-09-000103 333-68008 091239040 34 15243
2009-11-06 8-K nvlx8kcreeden.htm 5.02 0001262463-09-000091 333-68008 091164857 34 11378
2009-10-01 8-K nvlx8k1012009.htm 3.02 0001262463-09-000082 333-68008 091097681 34 12219
2009-09-17 10-Q nuvilexform10q20090731.htm 0001262463-09-000075 333-68008 091073714 34 604574
2009-09-15 8-K nvlx8k9152009.htm 5.02 0001262463-09-000074 333-68008 091070344 34 11050

Latest XBRL company facts

One latest value per concept from companyfacts (407 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 10.74M 2026-09-11 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
dei EntityPublicFloat Entity Public Float USD 6.28M 2025-10-31 2026 FY 10-K 2026-07-29 0001683168-26-005836
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 26.72M 2023-05-11 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 3.36M 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 735,199 2024-04-30 2025 FY 10-K 2025-08-11 0001683168-25-005821
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 390,535 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 58,096 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 70,000 2019-10-31 2020 Q2 10-Q 2019-12-23 0001683168-19-004051
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 2,581 2012-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2,581 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap AccretionExpense Accretion Expense USD 3.19M 2024-05-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 281,976 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 256,419 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 345,656 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 522,831 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap AccruedRentCurrent Accrued Rent, Current USD 0 2018-04-30 2018 FY 10-K 2018-07-20 0001683168-18-001994
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 421,941 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -21,411 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AcquiredFiniteLivedIntangibleAssetResidualValue Acquired Finite-lived Intangible Asset, Residual Value USD 2.00M 2016-01-31 2016 Q3 10-Q 2016-03-08 0001019687-16-005399
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 182.01M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 83,399 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -319,849 2023-05-01 2023-07-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 60,492 2025-05-01 2025-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 4.75M 2021-05-01 2022-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 100,000 2014-05-01 2015-01-31 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 6,497 2012-07-31 2013 Q1 10-Q 2012-09-19 0001262463-12-000355
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2014-05-01 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2013-05-01 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 61.99M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap Assets Assets USD 36.71M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AssetsCurrent Assets, Current USD 30.97M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap AssetsHeldForSaleOtherNoncurrent Assets Held-for-sale, Other, Noncurrent (Deprecated 2014-01-31) USD 0 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap AssetsHeldForSalePropertyPlantAndEquipment Assets Held-for-sale, Property, Plant and Equipment (Deprecated 2014-01-31) USD 1.03M 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap AssetsNoncurrent Assets, Noncurrent USD 5.74M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) USD 1.50M 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 0 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap Cash Cash USD 72.64M 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 17.74M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -2.66M 2014-05-01 2015-01-31 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 17.74M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -864,908 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 2.20M 2020-05-01 2021-01-31 2021 Q3 10-Q 2021-03-12 0001683168-21-000925
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 1.60M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 492,049 2014-05-01 2015-04-30 2015 FY 10-K 2015-07-29 0001019687-15-002894
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 33.99M 2018-04-30 2018 FY 10-K 2018-07-20 0001683168-18-001994
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 7.00M 2025-08-31 2026 Q1 10-Q 2025-09-15 0001683168-25-006991
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2018-10-31 2019 Q2 10-Q 2018-12-14 0001683168-18-003717
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-04-30 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 26.01M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 10.74M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 17.00M 2014-04-30 2015 Q1 10-Q 2014-09-15 0001019687-14-003582
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 0 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 50,000 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,602 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -5.08M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap ContractualObligation Contractual Obligation USD 220,000 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 720,000 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 66,001 2014-05-01 2015-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 54.00M 2013-05-01 2014-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 75,000 2013-05-01 2013-05-31 2015 Q1 10-Q 2014-09-15 0001019687-14-003582
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 888,889 2011-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap CostOfRevenue Cost of Revenue USD 0 2017-02-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2021-05-01 2021-07-31 2022 Q1 10-Q 2021-09-14 0001683168-21-004264
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 4.78M 2013-05-01 2014-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 20,000 2013-05-01 2014-04-30 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 4,229 2020-07-31 2021 Q1 10-Q 2020-09-11 0001683168-20-003111
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 75,200 2021-04-01 2021-04-28 2022 FY 10-K 2022-07-28 0001683168-22-005189
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 75,200 2020-03-27 2022 FY 10-K 2022-07-28 0001683168-22-005189
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.01 2020-03-01 2020-03-27 2022 FY 10-K 2022-07-28 0001683168-22-005189
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.08 2014-07-31 2015 Q1 10-Q 2014-09-15 0001019687-14-003582
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2020-05-01 2020-07-31 2021 Q1 10-Q 2020-09-11 0001683168-20-003111
us-gaap DeferredCompensationCashBasedArrangementsLiabilityCurrent Deferred Compensation Cash-based Arrangements, Liability, Current USD 0 2020-04-30 2020 FY 10-K 2020-08-13 0001683168-20-002680
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.69M 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 15.00M 2021-08-09 2022 Q2 10-Q 2022-12-14 0001683168-22-008428
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 174,862 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 559,672 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 19.37M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 63,232 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsInvestmentInSubsidiaries Deferred Tax Assets, Investment in Subsidiaries USD 511,464 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 439,953 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 19.37M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2020-04-30 2020 FY 10-K 2020-08-13 0001683168-20-002680
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 16.08M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 28.26M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 19.86M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 39.34M 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 217,244 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 569,229 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 0 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 0 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves USD 0 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 19.37M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 14.19M 2019-04-30 2019 FY 10-K 2019-08-13 0001683168-19-002559
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 754,512 2025-04-30 2025 FY 10-K 2025-08-11 0001683168-25-005821
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DepositAssets Deposit Assets USD 2.00M 2017-04-30 2018 Q3 10-Q 2018-03-19 0001683168-18-000720
us-gaap Depreciation Depreciation USD 0 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 0 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 2.00M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 29,746 2015-10-31 2016 Q2 10-Q 2015-12-10 0001019687-15-004472
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 700,000 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap DerivativeLiabilities Derivative Liability USD 29,746 2015-10-31 2016 Q2 10-Q 2015-12-10 0001019687-15-004472
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 281,000 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 1.30M 2023-05-01 2023-10-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap DividendIncomeOperating Dividend Income, Operating USD 240,884 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 32,491 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 1,577 2025-10-31 2026 Q2 10-Q 2025-12-18 0001683168-25-009259
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 83,399 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 50,908 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsPreferredStockPaidinkind Dividends, Preferred Stock, Paid-in-kind USD 32,491 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 83,399 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DividendsReceivable Dividends Receivable USD 429,150 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap DueToOfficersOrStockholders Due to Officers or Stockholders (Deprecated 2009-01-31) USD 134,705 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 0 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 292,000 2013-01-31 2013 Q3 10-Q 2013-03-26 0001445305-13-000706
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.54 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.21 2021-05-01 2022-01-31 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.54 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.154 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD 1,081 2021-05-01 2022-01-31 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -615 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 584 2022-05-01 2022-10-31 2022 Q2 10-Q 2022-12-14 0001683168-22-008428
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet Embedded Derivative, Fair Value of Embedded Derivative, Net USD 0 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 134,630 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap ExchangeFees Exchange Fees USD 36,000 2022-10-01 2022-10-06 2022 Q2 10-Q 2022-12-14 0001683168-22-008428
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 32,392 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 469,000 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2014-05-01 2015-04-30 2015 FY 10-K 2015-07-29 0001019687-15-002894
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.014 2014-05-01 2015-04-30 2015 FY 10-K 2015-07-29 0001019687-15-002894
us-gaap FairValueAssumptionsWeightedAverageVolatilityRate Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) pure 1.42 2014-05-01 2015-04-30 2015 FY 10-K 2015-07-29 0001019687-15-002894
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD 2.18M 2024-05-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 70,090 2023-05-01 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2024-05-01 2025-04-30 2025 FY 10-K 2025-08-11 0001683168-25-005821
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -416,000 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap GainLossOnNonRecourseDebt Gain (Loss) on Non-Recourse Debt USD -19,500 2013-05-01 2014-04-30 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap GainLossOnSaleOfDebtInvestments Gain (Loss) on Sale of Debt Investments USD 95,000 2010-05-01 2011-04-30 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 1.31M 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 5,876 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 946,708 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap GrossProfit Gross Profit USD 0 2017-02-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 1.55M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2019-05-01 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -1.95M 2011-05-01 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -19.42M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxesPaid Income Taxes Paid USD 800 2019-05-01 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 3.00M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-05-01 2019-04-30 2019 FY 10-K 2019-08-13 0001683168-19-002559
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.08M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -996,649 2023-05-01 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 27,998 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 78,384 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 8,970 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 0 2016-05-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 572,607 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2.14M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 355,918 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2014-05-01 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 45,909 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2014-05-01 2015-04-30 2015 FY 10-K/A 2016-01-19 0001019687-16-004856
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 119,433 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -177,175 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 0 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 0 2018-05-01 2019-01-31 2019 Q3 10-Q 2019-03-14 0001683168-19-000666
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 7,854 2013-05-01 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 123,509 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -69,653 2020-05-01 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 3.55M 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap IndefiniteLivedLicenseAgreements Indefinite-Lived License Agreements USD 3.55M 2022-04-30 2022 FY 10-K 2022-07-28 0001683168-22-005189
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap InterestAndOtherIncome Interest and Other Income USD 1,518 2014-05-01 2015-01-31 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap InterestExpense Interest Expense USD 0 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 16,023 2013-05-01 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap InterestIncomeOther Interest Income, Other USD 166,278 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1,539 2016-05-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap InterestPayableCurrent Interest Payable, Current USD 779 2021-04-28 2022 FY 10-K 2022-07-28 0001683168-22-005189
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 6,000 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap InventoryNet Inventory, Net USD 0 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 25,619 2021-05-01 2021-10-31 2022 Q2 10-Q 2021-12-14 0001683168-21-006337
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 0.145 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap Investments Investments USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 22.47M 2026-01-31 2026 Q3 10-Q 2026-03-17 0001683168-26-001917
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2024-05-01 2024-07-31 2025 Q1 10-Q 2024-09-17 0001683168-24-006441
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 905,680 2024-05-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 33,879 2017-05-01 2018-04-30 2018 FY 10-K 2018-07-20 0001683168-18-001994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1,158 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2,201 2022-01-31 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1,158 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap Liabilities Liabilities USD 6.90M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 36.71M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap LiabilitiesCurrent Liabilities, Current USD 768,682 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap LitigationReserve Estimated Litigation Liability USD 0 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap LitigationSettlementGain LitigationSettlementGain USD 106,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap LoansPayable Loans Payable USD 75,200 2021-01-31 2021 Q3 10-Q 2021-03-12 0001683168-21-000925
us-gaap LoansPayableCurrent Loans Payable, Current USD 0 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap LongTermDebt Long-term Debt USD 247,934 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.08 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 0 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 20,000 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 2.00M 2012-05-01 2012-05-31 2013 Q3 10-Q 2013-03-26 0001445305-13-000706
us-gaap LossContingencySettlementAgreementConsideration1 Loss Contingency, Settlement Agreement, Consideration (Deprecated 2013-01-31) USD 1.98M 2012-05-16 2013 Q3 10-Q 2013-03-26 0001445305-13-000706
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 99,462 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -154,548 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -83,399 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 4.88M 2016-05-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 2.00M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 0 2016-05-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -780,894 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -3.34M 2016-05-01 2017-04-30 2017 FY 10-K 2017-07-27 0001683168-17-001881
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.08M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -3.05M 2024-11-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -5.79M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 414,000 2024-05-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -4.07M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap NotesPayable Notes Payable USD 20,000 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap NotesPayableCurrent Notes Payable, Current USD 310,000 2012-07-31 2013 Q1 10-Q 2012-09-19 0001262463-12-000355
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 0 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OperatingExpenses Operating Expenses USD 1.01M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.01M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 28,374 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8,673 2021-07-31 2022 Q1 10-Q 2021-09-14 0001683168-21-004264
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 12,390 2020-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2,757 2016-04-30 2017 Q1 10-Q 2017-09-13 0001683168-17-002358
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 8,673 2021-07-31 2022 Q1 10-Q 2021-09-14 0001683168-21-004264
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 12,873 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 21,717 2019-07-31 2020 Q1 10-Q 2019-09-13 0001683168-19-002926
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 64.68M 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 287,310 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap OtherAssets Other Assets USD 7,688 2026-01-31 2026 Q3 10-Q 2026-03-17 0001683168-26-001917
us-gaap OtherAssetsCurrent Other Assets, Current USD 680,000 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 7,688 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD -615 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -615 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -210 2021-11-01 2022-01-31 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap OtherComprehensiveIncomeLossBeforeTax Other Comprehensive Income (Loss), before Tax USD 451 2023-05-01 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -615 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 0 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap OtherExpenses Other Expenses USD 2,080 2021-05-01 2021-10-31 2022 Q2 10-Q 2021-12-14 0001683168-21-006337
us-gaap OtherIncome Other Income USD -1,188 2020-05-01 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap OtherLiabilities Other Liabilities USD 6.13M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2014-01-31 2014 Q3 10-Q 2014-03-17 0001019687-14-000850
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2024-05-01 2025-04-30 2025 FY 10-K 2025-08-11 0001683168-25-005821
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 4,964 2022-05-01 2022-10-31 2022 Q2 10-Q 2022-12-14 0001683168-22-008428
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 1,515 2015-05-01 2016-01-31 2016 Q3 10-Q 2016-03-08 0001019687-16-005399
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -97 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -49,870 2011-05-01 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2024-05-01 2024-07-31 2025 Q1 10-Q 2024-09-17 0001683168-24-006441
us-gaap PaymentsForDeposits Payments for Deposits USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 702,061 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap PaymentsForProceedsFromPreviousAcquisition Payments for (Proceeds from) Previous Acquisition USD 1.57M 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap PaymentsForReinsurance Payments for Reinsurance USD 113,245 2020-05-01 2021-01-31 2021 Q3 10-Q 2021-03-12 0001683168-21-000925
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 401,625 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 2.57M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap PaymentsForRepurchaseOfPreferredStockAndPreferenceStock Payments for Repurchase of Preferred Stock and Preference Stock USD 0 2021-05-01 2021-07-31 2022 Q1 10-Q 2021-09-14 0001683168-21-004264
us-gaap PaymentsForRepurchaseOfRedeemablePreferredStock Payments for Repurchase of Redeemable Preferred Stock USD 5.77M 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 22.49M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.26M 2023-05-01 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap PaymentsToAcquireBusinessesAndInterestInAffiliates Payments to Acquire Businesses and Interest in Affiliates USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD -680,000 2011-05-01 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 3.00M 2025-05-01 2025-10-31 2026 Q2 10-Q 2025-12-18 0001683168-25-009259
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 5.00M 2023-05-01 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 621,217 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap PreferredStockConversionsInducements Preferred Stock Conversions, Inducements USD 640,000 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 1 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 600,000 2025-09-30 2026 Q1 10-Q 2025-09-15 0001683168-25-006991
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 22.86 2011-03-01 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 1,000 2025-08-31 2026 Q1 10-Q 2025-09-15 0001683168-25-006991
us-gaap PreferredStockRedemptionAmount Preferred Stock, Redemption Amount USD 3.51M 2024-07-31 2025 Q1 10-Q 2024-09-17 0001683168-24-006441
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 35,000 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 35,000 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap PrepaidExpense Prepaid Expense (Deprecated 2009-01-31) USD 10,944 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 32,004 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.85M 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 64,288 2010-05-01 2011-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 6.18M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 7.00M 2025-08-01 2025-08-31 2026 Q1 10-Q 2025-09-15 0001683168-25-006991
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 215,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 1.14M 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2022-05-01 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 70.00M 2021-08-10 2021-08-19 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap ProceedsFromLoans Proceeds from Loans USD 0 2020-05-01 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2013-05-01 2013-07-31 2014 Q1 10-Q 2013-09-16 0001157075-13-000015
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap ProceedsFromRepaymentsOfBankOverdrafts Proceeds from (Repayments of) Bank Overdrafts USD 0 2011-05-01 2011-10-31 2012 Q2 10-Q 2011-12-15 0001262463-11-000325
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD -1 2019-05-01 2020-04-30 2020 FY 10-K 2020-08-13 0001683168-20-002680
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 2,500 2011-05-01 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2020-05-01 2021-04-30 2021 FY 10-K 2021-08-10 0001683168-21-003377
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.05M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ProfessionalFees Professional Fees USD 1.21M 2024-05-01 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -4.19M 2022-05-01 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 54,440 2011-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap RecordedUnconditionalPurchaseObligationNonfinancialAssetsPledgedAsSecurityValue Recorded Unconditional Purchase Obligation, Nonfinancial Assets Pledged as Security, Value USD 2.50M 2013-01-31 2013 Q3 10-Q 2013-03-26 0001445305-13-000706
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap RepaymentsOfDebt Repayments of Debt USD 132,000 2012-05-01 2012-07-31 2013 Q1 10-Q 2012-09-19 0001262463-12-000355
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD -100,000 2011-05-01 2012-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 0 2022-05-01 2023-04-30 2023 FY 10-K 2023-07-31 0001683168-23-005175
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 60,000 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -109.47M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap Revenues Revenues USD 0 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 50,000 2010-05-01 2011-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 3.00M 2025-09-01 2025-09-30 2026 Q1 10-Q 2025-09-15 0001683168-25-006991
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2.52M 2021-08-01 2021-08-31 2022 Q2 10-Q 2022-12-14 0001683168-22-008428
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 0 2015-05-01 2016-01-31 2016 Q3 10-Q 2016-03-08 0001019687-16-005399
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 0 2015-05-01 2016-04-30 2016 FY 10-K 2016-07-29 0001019687-16-007057
us-gaap SellingExpense Selling Expense USD 108,979 2021-05-01 2021-10-31 2022 Q2 10-Q 2021-12-14 0001683168-21-006337
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 100,000 2014-05-01 2015-01-31 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap SettlementAssetsCurrent Settlement Assets, Current USD 0 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 0 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 892,500 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 5.00M 2015-05-01 2016-01-31 2016 Q3 10-Q 2016-03-08 0001019687-16-005399
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2019-05-01 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.91 2019-05-01 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.018 2019-05-01 2020-01-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2023-05-01 2023-07-31 2024 Q1 10-Q 2023-09-18 0001683168-23-006505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 279,802 2023-10-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.5 2023-10-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 25.00M 2014-05-01 2014-10-31 2015 Q2 10-Q 2014-12-15 0001019687-14-004716
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 127,500 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares 2.25M 2025-10-01 2025-10-31 2026 Q3 10-Q 2026-03-17 0001683168-26-001917
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 279,802 2023-10-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.5 2023-10-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2023-05-01 2024-01-31 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity USD 17.93M 2013-05-01 2014-04-30 2014 FY 10-K 2014-08-04 0001019687-14-002942
us-gaap SharePrice Share Price USD/shares 1.18 2025-01-31 2025 Q3 10-Q 2025-03-17 0001683168-25-001669
us-gaap ShareRepurchaseProgramExciseTax ShareRepurchaseProgramExciseTax USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap ShortTermBorrowings Short-term Debt USD 2.21M 2012-01-31 2012 Q3 10-Q 2012-03-21 0001262463-12-000081
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.1 2012-07-31 2013 Q1 10-Q 2012-09-19 0001262463-12-000355
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 27.51M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap StockIssued1 Stock Issued USD 80,000 2010-05-01 2011-04-30 2012 FY 10-K 2012-08-14 0001262463-12-000335
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1.02M 2011-05-01 2012-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1 2019-08-01 2019-10-31 2020 Q3 10-Q 2020-03-13 0001683168-20-000802
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 250,000 2013-05-01 2014-04-30 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 875,000 2025-12-10 2025-12-11 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 100.00M 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 23.57M 2011-05-01 2012-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 300,000 2014-05-01 2014-07-31 2015 Q1 10-Q 2014-09-15 0001019687-14-003582
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 70 2023-05-01 2024-04-30 2025 FY 10-K 2025-08-11 0001683168-25-005821
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2,278 2022-05-01 2023-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2023-05-01 2023-07-31 2024 Q2 10-Q 2023-12-15 0001683168-23-008889
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 45,500 2013-05-01 2014-04-30 2015 Q3 10-Q 2015-03-13 0001019687-15-000953
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 892,500 2025-12-10 2025-12-11 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 7,334 2022-05-01 2023-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 86,100 2014-05-01 2014-07-31 2015 Q1 10-Q 2014-09-15 0001019687-14-003582
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.65M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount USD 38,606 2020-11-01 2021-01-31 2021 Q3 10-Q 2021-03-12 0001683168-21-000925
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 393,750 2025-12-01 2025-12-31 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 401,625 2025-12-01 2025-12-31 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 2.57M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 26.72M 2023-05-11 2024 Q3 10-Q 2024-03-18 0001683168-24-001525
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 4.68M 2024-04-30 2024 FY 10-K 2024-08-13 0001683168-24-005575
us-gaap SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions pure 0.145 2012-05-01 2013-04-30 2013 FY 10-K 2013-07-29 0001157075-13-000010
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 3.27M 2023-05-01 2023-07-31 2025 Q1 10-Q 2024-09-17 0001683168-24-006441
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 15.27M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 45.01M 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap TreasuryStockShares Treasury Stock, Shares shares 3.39M 2023-01-31 2023 Q3 10-Q 2023-03-16 0001683168-23-001559
us-gaap TreasuryStockValue Treasury Stock, Value USD 40.28M 2023-07-31 2025 Q1 10-Q 2024-09-17 0001683168-24-006441
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD -5.79M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2015-05-01 2015-10-31 2016 Q2 10-Q/A 2016-01-19 0001019687-16-004860
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2016-01-31 2016 Q3 10-Q 2016-03-08 0001019687-16-005399
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2018-05-01 2019-01-31 2019 Q3 10-Q 2019-03-14 0001683168-19-000666
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 4.15M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-29 0001683168-26-005836
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 10.74M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 13.54M 2021-05-01 2022-01-31 2022 Q3 10-Q 2022-03-15 0001683168-22-001694
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 10.74M 2026-05-01 2026-07-31 2027 Q1 10-Q 2026-09-14 0001683168-26-007106

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →